Mankin Henry J, Casas-Ganem Jorge, Kim Jeung-Il, Gebhardt Mark C, Hornicek Francis J, Zeegen Erik N
Department of Orthopaedic Oncology Service, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Clin Orthop Relat Res. 2004 Apr(421):225-31. doi: 10.1097/01.blo.0000119250.08614.82.
Leiomyosarcoma is a rare, aggressively malignant connective tissue tumor of mature adults, which arises from smooth muscle. It occurs most frequently in the uterus, bowel, vascular tissues, and less commonly in somatic soft tissue or bone. The tumor when it arises in soft tissue has distinctive histologic features which somewhat resemble malignant fibrous histiocytoma (otherwise known as myxofibrosarcoma). The Orthopaedic Oncology Service at our institution has treated 66 patients with these lesions and thus far, 1/2 of the patients have died of disease at a mean of 3 years after discovery. Factors that increase the death rate include size of the tumor, Musculoskeletal Tumor Society Stage of disease, and to a lesser extent particularly in the lower extremities, anatomic site. Radiation and chemotherapy had little direct effect on the outcome but patients treated with surgery and adjunctive agents seemed to live longer than their cohorts treated with surgery alone. The purpose of this study is a general review of the clinical and prognostic features of this cancer.
平滑肌肉瘤是一种罕见的、侵袭性恶性结缔组织肿瘤,发生于成熟成年人,起源于平滑肌。它最常发生于子宫、肠道、血管组织,较少见于躯体软组织或骨骼。当肿瘤发生于软组织时,具有独特的组织学特征, somewhat resemble恶性纤维组织细胞瘤(也称为黏液纤维肉瘤)。我们机构的骨肿瘤服务部门治疗了66例患有这些病变的患者,到目前为止,一半的患者在发现后平均3年死于该疾病。增加死亡率的因素包括肿瘤大小、肌肉骨骼肿瘤学会疾病分期,以及在较小程度上特别是在下肢的解剖部位。放疗和化疗对预后几乎没有直接影响,但接受手术和辅助药物治疗的患者似乎比仅接受手术治疗的同龄人寿命更长。本研究的目的是对这种癌症的临床和预后特征进行全面综述。